Comprehensive magnetic resonance of peripheral arterial disease

Trial Profile

Comprehensive magnetic resonance of peripheral arterial disease

Phase of Trial: Phase III

Latest Information Update: 23 Aug 2017

At a glance

  • Drugs Ezetimibe (Primary) ; Ezetimibe/simvastatin (Primary) ; Simvastatin (Primary)
  • Indications Atherosclerosis; Peripheral arterial disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Feb 2012 Actual patient number changed from 67 to 85 as reported by
    • 02 Feb 2012 Status changed from active, no longer recruiting to completed as reported by
    • 03 Oct 2011 Actual patient numbers changed to 67 as reported in Atherosclerosis.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top